Publication
Synthesis and anti-HIV activity of conformationally restricted bicyclic hexahydroisobenzofuran nucleoside analogs
Downloadable Content
- Persistent URL
- Last modified
- 05/21/2025
- Type of Material
- Authors
- Language
- English
- Date
- 2009-01-01
- Publisher
- ROYAL SOC CHEMISTRY
- Publication Version
- Copyright Statement
- 2009
- Final Published Version (URL)
- Title of Journal or Parent Work
- Volume
- 7
- Issue
- 7
- Start Page
- 1415
- End Page
- 1423
- Grant/Funding Information
- Financial support of this work by the Spanish Ministerio de Educación y Ciencia (MEC) (Project MEC-07-CTQ-61126) is gratefully acknowledged. A. D.-R. thanks MEC for a predoctoral fellowship. We also thank Dr A. G. DiPasquale and Professor A. L. Rheingold (UCSD X-Ray Facility) for the reported crystallographic studies and Dr Y. Su (UCSD Mass Spectrometry Facility) for mass analysis and the NSF (CHE-0116662, CHE-9709183 and CHE-0741968) for NMR and MS instrumentation grants. R. F. S. is supported in part by NIH grants 5P30-AI-50409 (CFAR), 5R37-AI-041980 and by the Department of Veterans Affairs.
- Supplemental Material (URL)
- Abstract
- A chiral synthesis of a series of hexahydroisobenzofuran (HIBF) nucleosides has been accomplished via glycosylation of a stereo-defined (syn-isomer) sugar motif 16 with the appropriate silylated bases. All nucleoside analogs were obtained in 52-71% yield as a mixture of α- and β-anomeric products increasing the breadth of the novel nucleosides available for screening. The structure of the novel bicyclic HIBF nucleosides was established by a single crystal X-ray structure of the β-HIBF thymine analog 22b. Furthermore, the sugar conformation for these nucleosides was established as N-type. Among the novel HIBF nucleosides synthesized, twenty-five compounds were tested as inhibitor of HIV-1 in human peripheral blood mononuclear (PBM) cells and seven were found to be active (EC50 = 12.3-36.2 μM). Six of these compounds were purine analogs with β-HIBF inosine analog 22o being the most potent (EC50 = 12.3 μM) among all compounds tested. The striking resemblance between didanosine (ddI) and 22o may explain the potent anti-HIV activity. © 2009 The Royal Societ of Chemistry.
- Author Notes
- Keywords
- Research Categories
- Health Sciences, Public Health
- Chemistry, Organic
- Biology, Virology
Tools
- Download Item
- Contact Us
-
Citation Management Tools
Relations
- In Collection:
Items
| Thumbnail | Title | File Description | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|---|
|
|
Publication File - vrht7.pdf | Primary Content | 2025-05-07 | Public | Download |